share_log

BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study

BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study

Brief-Mateon治療公司表示,本週第一名患者登記參加其IV期研究
Reuters ·  2020/10/07 07:43

Oct 7 (Reuters) - Mateon Therapeutics Inc MATN.PK :

路透10月7日電-Mateon治療公司MATN.PK:

* MATEON THERAPEUTICS INC - ANNOUNCED FIRST PATIENT ENROLLED THIS WEEK IN ITS PHASE IV STUDY ARTI-19

*MATEON治療公司-本週宣佈第一名患者參加其第四階段研究ARTI-19

* MATEON THERAPEUTICS INC - TOP-LINE DATA FROM ARTI-19 IS EXPECTED BY END OF 4Q20

*MATEON治療公司-ARTI-19的一線數據預計將在20年第四季度末公佈

Source text for Eikon: Further company coverage:

Eikon的源文本:進一步的公司報道:

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論